Carbonyl Posttranslational Modification Associated With Early-Onset Type 1 Diabetes Autoimmunity.

MLA

Yang, Mei-Ling, et al. “Carbonyl Posttranslational Modification Associated With Early-Onset Type 1 Diabetes Autoimmunity.” Diabetes, vol. 71, no. 9, Sept. 2022, pp. 1979–93. EBSCOhost, https://doi.org/10.2337/db21-0989.

APA

Yang, M.-L., Connolly, S. E., Gee, R. J., Lam, T. T., Kanyo, J., Peng, J., Guyer, P., Syed, F., Tse, H. M., Clarke, S. G., Clarke, C. F., James, E. A., Speake, C., Evans-Molina, C., Arvan, P., Herold, K. C., Wen, L., & Mamula, M. J. (2022). Carbonyl Posttranslational Modification Associated With Early-Onset Type 1 Diabetes Autoimmunity. Diabetes, 71(9), 1979–1993. https://doi.org/10.2337/db21-0989

Chicago

Yang, Mei-Ling, Sean E Connolly, Renelle J Gee, TuKiet T Lam, Jean Kanyo, Jian Peng, Perrin Guyer, et al. 2022. “Carbonyl Posttranslational Modification Associated With Early-Onset Type 1 Diabetes Autoimmunity.” Diabetes 71 (9): 1979–93. doi:10.2337/db21-0989.